GDNF and neurodegenerative disease: Although the Rheb–mTOR signaling pathway may act as a double-edged sword in neurodegeneration, it is a central regulator of NTFs such as BDNF, CNTF, and GDNF and thus is a potential therapeutic target for neurodegenerative diseases.